Global Gastrointestinal OTC Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Gastrointestinal OTC Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Market Segment by Application
1.3.1 Global Gastrointestinal OTC Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Gastrointestinal OTC Drugs Market Size (2017-2028)
2.1.1 Global Gastrointestinal OTC Drugs Revenue (2017-2028)
2.1.2 Global Gastrointestinal OTC Drugs Sales (2017-2028)
2.2 Global Gastrointestinal OTC Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Gastrointestinal OTC Drugs Sales by Regions (2017-2022)
2.2.2 Global Gastrointestinal OTC Drugs Revenue by Regions (2017-2022)
2.3 Global Gastrointestinal OTC Drugs Market Size Forecast by Region
2.3.1 Global Gastrointestinal OTC Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Gastrointestinal OTC Drugs Regions (Countries) Ranking by Market Size
2.5 Gastrointestinal OTC Drugs Market Dynamics
2.5.1 Gastrointestinal OTC Drugs Market Trends
2.5.2 Gastrointestinal OTC Drugs Market Drivers
2.5.3 Gastrointestinal OTC Drugs Market Challenges
2.5.4 Gastrointestinal OTC Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Gastrointestinal OTC Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Gastrointestinal OTC Drugs Sales in 2021
3.2 Global Top Manufacturers Gastrointestinal OTC Drugs by Revenue
3.2.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Gastrointestinal OTC Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2021)
3.4 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Gastrointestinal OTC Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Gastrointestinal OTC Drugs Market
3.7 Key Manufacturers Gastrointestinal OTC Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gastrointestinal OTC Drugs Market Size by Type
4.1 Global Gastrointestinal OTC Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Gastrointestinal OTC Drugs Price by Type (2017-2022)
4.2 Global Gastrointestinal OTC Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Gastrointestinal OTC Drugs Price Forecast by Type (2023-2028)
5 Global Gastrointestinal OTC Drugs Market Size by Application
5.1 Global Gastrointestinal OTC Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Gastrointestinal OTC Drugs Price by Application (2017-2022)
5.2 Global Gastrointestinal OTC Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Gastrointestinal OTC Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Company
6.1.1 North America Gastrointestinal OTC Drugs Sales by Company (2017-2022)
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Company (2017-2022)
6.2 North America Gastrointestinal OTC Drugs Market Size by Type
6.2.1 North America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
6.2.2 North America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
6.3 North America Gastrointestinal OTC Drugs Market Size by Application
6.3.1 North America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
6.3.2 North America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
6.4 North America Gastrointestinal OTC Drugs Market Size by Country
6.4.1 North America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
6.4.2 North America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Gastrointestinal OTC Drugs Sales Breakdown by Company
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Company (2017-2022)
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Company (2017-2022)
7.2 Europe Gastrointestinal OTC Drugs Market Size by Type
7.2.1 Europe Gastrointestinal OTC Drugs Sales by Type (2017-2028)
7.2.2 Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
7.3 Europe Gastrointestinal OTC Drugs Market Size by Application
7.3.1 Europe Gastrointestinal OTC Drugs Sales by Application (2017-2028)
7.3.2 Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
7.4 Europe Gastrointestinal OTC Drugs Market Size by Country
7.4.1 Europe Gastrointestinal OTC Drugs Sales by Country (2017-2028)
7.4.2 Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal OTC Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Type
8.2.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Gastrointestinal OTC Drugs Market Size by Application
8.3.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
8.4.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.4.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Company
9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Company (2017-2022)
9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Company (2017-2022)
9.2 Latin America Gastrointestinal OTC Drugs Market Size by Type
9.2.1 Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
9.2.2 Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
9.3 Latin America Gastrointestinal OTC Drugs Market Size by Application
9.3.1 Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
9.3.2 Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
9.4 Latin America Gastrointestinal OTC Drugs Market Size by Country
9.4.1 Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
9.4.2 Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Type
10.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Application
10.3.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country
10.4.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products and Services
11.1.5 GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Pfizer Gastrointestinal OTC Drugs Products and Services
11.2.5 Pfizer Gastrointestinal OTC Drugs SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products and Services
11.3.5 Johnson & Johnson Gastrointestinal OTC Drugs SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Bayer Gastrointestinal OTC Drugs Products and Services
11.4.5 Bayer Gastrointestinal OTC Drugs SWOT Analysis
11.4.6 Bayer Recent Developments
11.5 Procter & Gamble
11.5.1 Procter & Gamble Corporation Information
11.5.2 Procter & Gamble Overview
11.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products and Services
11.5.5 Procter & Gamble Gastrointestinal OTC Drugs SWOT Analysis
11.5.6 Procter & Gamble Recent Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Overview
11.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Perrigo Gastrointestinal OTC Drugs Products and Services
11.6.5 Perrigo Gastrointestinal OTC Drugs SWOT Analysis
11.6.6 Perrigo Recent Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Abbott Gastrointestinal OTC Drugs Products and Services
11.7.5 Abbott Gastrointestinal OTC Drugs SWOT Analysis
11.7.6 Abbott Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Sanofi Gastrointestinal OTC Drugs Products and Services
11.8.5 Sanofi Gastrointestinal OTC Drugs SWOT Analysis
11.8.6 Sanofi Recent Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Overview
11.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products and Services
11.9.5 Teva Pharmaceutical Gastrointestinal OTC Drugs SWOT Analysis
11.9.6 Teva Pharmaceutical Recent Developments
11.10 Nestle
11.10.1 Nestle Corporation Information
11.10.2 Nestle Overview
11.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Nestle Gastrointestinal OTC Drugs Products and Services
11.10.5 Nestle Gastrointestinal OTC Drugs SWOT Analysis
11.10.6 Nestle Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Corporation Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products and Services
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Reckitt Benckiser
11.12.1 Reckitt Benckiser Corporation Information
11.12.2 Reckitt Benckiser Overview
11.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Products and Services
11.12.5 Reckitt Benckiser Recent Developments
11.13 Purdue Pharma
11.13.1 Purdue Pharma Corporation Information
11.13.2 Purdue Pharma Overview
11.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Purdue Pharma Gastrointestinal OTC Drugs Products and Services
11.13.5 Purdue Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Gastrointestinal OTC Drugs Value Chain Analysis
12.2 Gastrointestinal OTC Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastrointestinal OTC Drugs Production Mode & Process
12.4 Gastrointestinal OTC Drugs Sales and Marketing
12.4.1 Gastrointestinal OTC Drugs Sales Channels
12.4.2 Gastrointestinal OTC Drugs Distributors
12.5 Gastrointestinal OTC Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Laxatives
Table 3. Major Manufacturers of Anti-Flatulents
Table 4. Major Manufacturers of H2-Antaginists
Table 5. Major Manufacturers of Anti-Diarrheals
Table 6. Major Manufacturers of PPIs
Table 7. Major Manufacturers of Anti-Emetics
Table 8. Major Manufacturers of Other
Table 9. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Gastrointestinal OTC Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Dose)
Table 12. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022)
Table 13. Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2023-2028) & (K Dose)
Table 16. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Region (2023-2028)
Table 17. Global Gastrointestinal OTC Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 19. Top Gastrointestinal OTC Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 20. Gastrointestinal OTC Drugs Market Trends
Table 21. Gastrointestinal OTC Drugs Market Drivers
Table 22. Gastrointestinal OTC Drugs Market Challenges
Table 23. Gastrointestinal OTC Drugs Market Restraints
Table 24. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2017-2022) & (K Dose)
Table 25. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2017-2022)
Table 26. Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Ranking of Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 28. Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2017-2022)
Table 29. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2021)
Table 31. Key Manufacturers Gastrointestinal OTC Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 32. Key Manufacturers Gastrointestinal OTC Drugs Plants/Factories Distribution
Table 33. Key Manufacturers Gastrointestinal OTC Drugs Area Served
Table 34. Date of Key Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table 35. Key Manufacturers Gastrointestinal OTC Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Gastrointestinal OTC Drugs Sales (K Dose) by Type (2017-2022)
Table 38. Global Gastrointestinal OTC Drugs Sales Share by Type (2017-2022)
Table 39. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 40. Global Gastrointestinal OTC Drugs Price (K Dose) by Type (2017-2022)
Table 41. Global Gastrointestinal OTC Drugs Sales (K Dose) by Type (2023-2028)
Table 42. Global Gastrointestinal OTC Drugs Sales Share by Type (2023-2028)
Table 43. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 44. Global Gastrointestinal OTC Drugs Revenue Share by Type (2023-2028)
Table 45. Global Gastrointestinal OTC Drugs Price (K Dose) by Type (2023-2028)
Table 46. Global Gastrointestinal OTC Drugs Sales (K Dose) by Application (2017-2022)
Table 47. Global Gastrointestinal OTC Drugs Sales Share by Application (2017-2022)
Table 48. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 49. Global Gastrointestinal OTC Drugs Price (K Dose) by Application (2017-2022)
Table 50. Global Gastrointestinal OTC Drugs Sales (K Dose) by Application (2023-2028)
Table 51. Global Gastrointestinal OTC Drugs Sales Share by Application (2023-2028)
Table 52. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 53. Global Gastrointestinal OTC Drugs Revenue Share by Application (2023-2028)
Table 54. Global Gastrointestinal OTC Drugs Price (K Dose) by Application (2023-2028)
Table 55. North America Gastrointestinal OTC Drugs Sales by Company (2017-2022) & (K Dose)
Table 56. North America Gastrointestinal OTC Drugs Sales Market Share by Company (2017-2022)
Table 57. North America Gastrointestinal OTC Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 58. North America Gastrointestinal OTC Drugs Revenue Market Share by Company (2017-2022)
Table 59. North America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose)
Table 60. North America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Dose)
Table 61. North America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Dose)
Table 64. North America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Dose)
Table 65. North America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose)
Table 68. North America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Dose)
Table 69. North America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe Gastrointestinal OTC Drugs Sales by Company (2017-2022) & (K Dose)
Table 72. Europe Gastrointestinal OTC Drugs Sales Market Share by Company (2017-2022)
Table 73. Europe Gastrointestinal OTC Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 74. Europe Gastrointestinal OTC Drugs Revenue Market Share by Company (2017-2022)
Table 75. Europe Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose)
Table 76. Europe Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Dose)
Table 77. Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 78. Europe Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 79. Europe Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Dose)
Table 80. Europe Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Dose)
Table 81. Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 82. Europe Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 83. Europe Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose)
Table 84. Europe Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Dose)
Table 85. Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 86. Europe Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 87. Asia Pacific Gastrointestinal OTC Drugs Sales by Company (2017-2022) & (K Dose)
Table 88. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Company (2017-2022)
Table 89. Asia Pacific Gastrointestinal OTC Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 90. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Company (2017-2022)
Table 91. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose)
Table 92. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Dose)
Table 93. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 94. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 95. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Dose)
Table 96. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Dose)
Table 97. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 98. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 99. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Dose)
Table 100. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Dose)
Table 101. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 102. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 103. Latin America Gastrointestinal OTC Drugs Sales by Company (2017-2022) & (K Dose)
Table 104. Latin America Gastrointestinal OTC Drugs Sales Market Share by Company (2017-2022)
Table 105. Latin America Gastrointestinal OTC Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 106. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Company (2017-2022)
Table 107. Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose)
Table 108. Latin America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Dose)
Table 109. Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 111. Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Dose)
Table 112. Latin America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Dose)
Table 113. Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 114. Latin America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 115. Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose)
Table 116. Latin America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Dose)
Table 117. Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 118. Latin America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 119. Middle East and Africa Gastrointestinal OTC Drugs Sales by Company (2017-2022) & (K Dose)
Table 120. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Company (2017-2022)
Table 121. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Company (2017-2022)
Table 123. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Dose)
Table 124. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Dose)
Table 125. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Dose)
Table 128. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Dose)
Table 129. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 131. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Dose)
Table 132. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Dose)
Table 133. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Overview
Table 137. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 138. GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
Table 139. GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
Table 140. GlaxoSmithKline Recent Developments
Table 141. Pfizer Corporation Information
Table 142. Pfizer Description and Overview
Table 143. Pfizer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 144. Pfizer Gastrointestinal OTC Drugs Product and Services
Table 145. Pfizer Gastrointestinal OTC Drugs SWOT Analysis
Table 146. Pfizer Recent Developments
Table 147. Johnson & Johnson Corporation Information
Table 148. Johnson & Johnson Description and Overview
Table 149. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 150. Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
Table 151. Johnson & Johnson Gastrointestinal OTC Drugs SWOT Analysis
Table 152. Johnson & Johnson Recent Developments
Table 153. Bayer Corporation Information
Table 154. Bayer Description and Overview
Table 155. Bayer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 156. Bayer Gastrointestinal OTC Drugs Product and Services
Table 157. Bayer Gastrointestinal OTC Drugs SWOT Analysis
Table 158. Bayer Recent Developments
Table 159. Procter & Gamble Corporation Information
Table 160. Procter & Gamble Description and Overview
Table 161. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 162. Procter & Gamble Gastrointestinal OTC Drugs Product and Services
Table 163. Procter & Gamble Gastrointestinal OTC Drugs SWOT Analysis
Table 164. Procter & Gamble Recent Developments
Table 165. Perrigo Corporation Information
Table 166. Perrigo Description and Overview
Table 167. Perrigo Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 168. Perrigo Gastrointestinal OTC Drugs Product and Services
Table 169. Perrigo Gastrointestinal OTC Drugs SWOT Analysis
Table 170. Perrigo Recent Developments
Table 171. Abbott Corporation Information
Table 172. Abbott Description and Overview
Table 173. Abbott Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 174. Abbott Gastrointestinal OTC Drugs Product and Services
Table 175. Abbott Gastrointestinal OTC Drugs SWOT Analysis
Table 176. Abbott Recent Developments
Table 177. Sanofi Corporation Information
Table 178. Sanofi Description and Overview
Table 179. Sanofi Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 180. Sanofi Gastrointestinal OTC Drugs Product and Services
Table 181. Sanofi Gastrointestinal OTC Drug

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs